Novo Nordisk A/S

XTRA:NOV Stock Report

Market Cap: €422.4b

Novo Nordisk Future Growth

Future criteria checks 3/6

Novo Nordisk is forecast to grow earnings and revenue by 14.4% and 12.9% per annum respectively. EPS is expected to grow by 14.7% per annum. Return on equity is forecast to be 94.5% in 3 years.

Key information

14.4%

Earnings growth rate

14.7%

EPS growth rate

Pharmaceuticals earnings growth20.3%
Revenue growth rate12.9%
Future return on equity94.5%
Analyst coverage

Good

Last updated15 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

XTRA:NOV - Analysts future estimates and past financials data (DKK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026403,442148,413119,462162,82921
12/31/2025343,304124,80794,089139,55924
12/31/2024286,604101,11768,005121,79420
9/30/2024270,58394,72167,031118,218N/A
6/30/2024258,00389,89866,027115,334N/A
3/31/2024244,24389,27650,30493,408N/A
12/31/2023232,26183,68370,012108,908N/A
9/30/2023214,49075,31277,825106,458N/A
6/30/2023201,32567,23967,49789,731N/A
3/31/2023188,29061,12967,34185,115N/A
12/31/2022176,95455,52564,13478,887N/A
9/30/2022167,19552,82557,87568,769N/A
6/30/2022157,25150,53957,68066,037N/A
3/31/2022149,02749,34459,66567,331N/A
12/31/2021140,80047,75747,61555,000N/A
9/30/2021134,60546,18340,21358,189N/A
6/30/2021129,91044,36231,81454,188N/A
3/31/2021126,87542,86431,33753,194N/A
12/31/2020126,94642,13829,87051,951N/A
9/30/2020127,22541,53744,80056,944N/A
6/30/2020126,57541,43347,62156,126N/A
3/31/2020126,60540,40336,98746,904N/A
12/31/2019122,02138,95135,55146,782N/A
9/30/2019119,33638,73136,78549,029N/A
6/30/2019116,82137,57431,25143,960N/A
3/31/2019114,19238,32232,20244,691N/A
12/31/2018111,83138,62832,20644,616N/A
9/30/2018110,09138,38431,57643,236N/A
6/30/2018108,94339,117N/A44,538N/A
3/31/2018110,17438,725N/A38,885N/A
12/31/2017111,69638,130N/A41,168N/A
9/30/2017113,27638,576N/A46,289N/A
6/30/2017114,19938,609N/A48,557N/A
3/31/2017113,02038,626N/A52,937N/A
12/31/2016111,78037,925N/A48,314N/A
9/30/2016111,08437,484N/A47,280N/A
6/30/2016110,33936,064N/A44,179N/A
3/31/2016109,93934,439N/A41,656N/A
12/31/2015107,92734,860N/A38,287N/A
9/30/2015103,63633,131N/A35,469N/A
6/30/201599,09331,248N/A35,578N/A
3/31/201593,66329,899N/A31,729N/A
12/31/201488,80626,481N/A31,692N/A
9/30/201485,91926,005N/A29,763N/A
6/30/201484,18125,920N/A23,783N/A
3/31/201483,93225,660N/A22,941N/A
12/31/201383,57225,184N/A25,942N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NOV's forecast earnings growth (14.4% per year) is above the savings rate (1%).

Earnings vs Market: NOV's earnings (14.4% per year) are forecast to grow slower than the German market (20.8% per year).

High Growth Earnings: NOV's earnings are forecast to grow, but not significantly.

Revenue vs Market: NOV's revenue (12.9% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: NOV's revenue (12.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: NOV's Return on Equity is forecast to be very high in 3 years time (94.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y